No sides. Just data.

We compare what the media report with what the data say

World · International

Controversial US-backed vaccine trial in African newborns halted

Outlet: The Guardian · Melody Schreiber · Published 21/10/2026 17:18 UTC

Only The Guardian reports this: no contrast yet

None of the other outlets we follow has reported this story, so there are no versions to compare. If others publish it or data appear that test it, it will move to the comparison.

Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...

Read on the original outlet ↗

Changes detected 1

The outlet changed this story after we captured it. We keep the previous version, its fingerprint and the date we saw the change.

  1. Excerpt · detected on 21/10/2026 18:08 UTC

    Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...

    See versions and fingerprints

    Before: «Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It is “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...» 20d4f6385930

    After: «Hepatitis B study in Guinea-Bissau that was to be funded by CDC and that drew global backlash ‘will not move forward’ The US-backed hepatitis B vaccine trial in African newborns that drew global backlash was halted, the lead researcher said on Wednesday. It was “now clear” that the study “will not move forward in Guinea-Bissau”, Frederik Schaltz-Buchholzer, a Danish researcher, wrote on LinkedIn, adding, “we were not given the necessary governmental approval.” Continue reading...» cff6f781e501

Capture record
Source
https://www.theguardian.com/world/2026/oct/21/us-vaccine-trial-african-newborns-hepatitis-b
Published
21/10/2026 17:18 UTC
Captured
21/10/2026 17:39 UTC
Text fingerprint
1738fbc19a3dea41 · 846 words
Changes detected
1
Archived copy
Wayback Machine ↗

The fingerprint (sha256) and the capture date prove what the story said when we analysed it, even if it changes later.

More contrasts in world